CURRENT COLLABORATION PARTNERS
CellProtect Nordic Pharmaceuticals AB is currently involved in two collaborations:
- Commercial partner of the 25 MSEK VINNOVA consortium “Cell Therapies”.
- Collaboration with Hematology Centre, Karolinska University Hospital Huddinge for the conduction of Phase I/II trial in multiple myeloma patients.
CPNP is particularly interested in partnerships with the following objectives:
- continued clinical development of cell therapies.
- commercialization of CellProtect (including health care providers and clinics).
Please contact the CEO on email@example.com for more information.